Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.

Pharmaceutical Outsourcing Present and Future

The need for preclinical testing expertise is growing as molecular complexity increases.

Navigating the Preclinical CRO Outsourcing Process

A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.

A Closer Look at Affinity Ligands

Topic

Susan J. Schniepp is a fellow at Regulatory Compliance Associates, Inc. and a member of Pharmaceutical Technology's Editorial Advisory Board.

Articles

Key talks from the recent PDA/FDA regulatory conference highlight room for improvement.

Advice for Enhancing the Client–Sponsor Relationship

To support global stability practices, fundamental basics must be in place.

Stability Program Management

Stephanie Sutton was an assistant editor at Pharmaceutical Technology Europe.

Patheon will acquire softgel-specialist company Banner Pharmacaps, based in North Carolina in the US, for $255 million

Patheon to Acquire Banner Pharmacaps

Consider the time and expertise needed to maintain regulatory compliance and perform stability testing.

Considerations for Outsourcing Stability Storage

Consider these tools and strategies for optimizing the manufacturing process.

Challenges in Topical Drug Manufacturing

Today's pharmaceutical companies are striving to reduce costs and maximize efficiencies, and must make decisions on the best way to deploy their limited resources.

Outsourcing Pharmaceutical Infrastructure Operations

Working together affords many unseen opportunities for pharmaceutical innovation.

Partnerships Remain Crucial to Future Development

Jim Miller is president of PharmSource Information Services, Inc., and publisher of Bio/Pharmaceutical Outsourcing Report.

Measuring the size of the market for contract manufacturing services requires a careful hand.

Sizing the Market for Contract Manufacturing

The weak global economy adds to the challenges of bio/pharma companies and their suppliers.

The Macro View

Eric Langer has over 25 years experience in biotechnology and life sciences strategic marketing management, market research, and publishing. He has held senior management and marketing positions at biopharmaceutical supply companies. He has published and authored many books and reports on topics in Biotechnology, Large-scale BioManufacturing, and bioscience commercialization and communication. He teaches at Johns Hopkins University marketing management, biotech marketing, services marketing, and marketing in a regulated environment. In 1989 he co-founded BioPlan Associates, Inc. to provide market analysis, and strategy to biotech and healthcare organizations.

Budgets for biopharmaceutical activities are gaining in select functional areas except outsourcing.